Eight Member States have reported a total of 115 deaths and 191 acute intoxications where α-PVP was detected. In most cases, the use of α-PVP was combined with other pharmacologically active substances, either intentionally or unintentionally. If α-PVP were to become more widely available and used, the implications for individual and public health could be significant.
Recital 3, Decision_act (EU) 2016/1070
In forcesince 27 Jun 2016